Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Soleno Therapeutics, Inc. SLNO

Full chart Compare
Set alert

Price alert · SLNO

All alert types
53.01 USD 0.00 (+0.00%)

At closeMay 15, 2026, 4:00 PM EDT

52.99 -0.02 -0.04%

After hours · May 15, 4:00 PM ET

52.98 Day range 53.01

52-week range unavailable

YTD
+14.49%
1 year
-29.33%

Financial health

Altman Z-Score

15.37 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 113×
FY 2016: -5.2×FY 2017: -5.2×FY 2018: -13.4×FY 2019: -14.0×FY 2020: -39.3×FY 2021: -5.3×FY 2022: -3.4×FY 2023: -17.1×FY 2024: -10.3×FY 2025: 113×
FY 2016 5y median -5.3× FY 2025
P/S 12.9×
FY 2016: 43.3×FY 2017: -0.1×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 12.9×
FY 2016 5y median 0.0× FY 2025
P/B 5.5×
FY 2016: 18.3×FY 2017: 3.0×FY 2018: 5.9×FY 2019: 33.6×FY 2020: 13.3×FY 2021: 9.2×FY 2022: 8.0×FY 2023: 4.2×FY 2024: 7.4×FY 2025: 5.5×
FY 2016 5y median 7.4× FY 2025
P/FCF 52.7×
FY 2016: -4.6×FY 2017: -8.1×FY 2018: -15.3×FY 2019: -28.9×FY 2020: -24.0×FY 2021: -5.9×FY 2022: -4.0×FY 2023: -26.6×FY 2024: -26.1×FY 2025: 52.7×
FY 2016 5y median -5.9× FY 2025
EV/EBITDA 84.4×
FY 2016: -8.9×FY 2017: -5.4×FY 2018: -13.3×FY 2019: -16.7×FY 2020: -24.5×FY 2021: -4.7×FY 2022: -3.1×FY 2023: -13.4×FY 2024: -10.2×FY 2025: 84.4×
FY 2016 5y median -4.7× FY 2025
EV/Sales 12.6×
FY 2016: 41.4×FY 2017: -0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 12.6×
FY 2016 5y median 0.0× FY 2025
FCF Yield 1.9%
FY 2016: -21.6%FY 2017: -12.3%FY 2018: -6.5%FY 2019: -3.5%FY 2020: -4.2%FY 2021: -17.0%FY 2022: -25.0%FY 2023: -3.8%FY 2024: -3.8%FY 2025: 1.9%
FY 2016 5y median -3.8% FY 2025

Profitability

Gross Margin 98.6%
FY 2016: -4.0%FY 2017: 100.1%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 98.6%
FY 2016 5y median 0.0% FY 2025
Operating Margin 7.9%
FY 2016: -938.1%FY 2017: 0.8%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 7.9%
FY 2016 5y median 0.0% FY 2025
Net Margin 11.0%
FY 2016: -831.6%FY 2017: 1.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 11.0%
FY 2016 5y median 0.0% FY 2025
ROE 4.6%
FY 2016: -351.2%FY 2017: -59.0%FY 2018: -43.8%FY 2019: -205.9%FY 2020: -54.1%FY 2021: -173.7%FY 2022: -232.6%FY 2023: -24.8%FY 2024: -71.7%FY 2025: 4.6%
FY 2016 5y median -71.7% FY 2025
ROIC 3.0%
FY 2016: -352.8%FY 2017: -28.7%FY 2018: -34.6%FY 2019: -69.2%FY 2020: -56.5%FY 2021: -113.3%FY 2022: -126.2%FY 2023: -24.4%FY 2024: -60.0%FY 2025: 3.0%
FY 2016 5y median -60.0% FY 2025
ROA 3.7%
FY 2016: -216.8%FY 2017: -40.2%FY 2018: -30.9%FY 2019: -80.6%FY 2020: -37.9%FY 2021: -86.9%FY 2022: -90.8%FY 2023: -21.6%FY 2024: -53.1%FY 2025: 3.7%
FY 2016 5y median -53.1% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 274.3%FY 2017: -107145.4%FY 2018: 100.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 108.0%
FY 2016: -11.9%FY 2017: 10.6%FY 2018: -17.5%FY 2019: -62.2%FY 2020: -37.7%FY 2021: 1.3%FY 2022: 22.6%FY 2023: -69.6%FY 2024: -353.5%FY 2025: 108.0%
FY 2016 FY 2025
EPS (diluted) 108.9%
FY 2016: 53.9%FY 2017: 55.1%FY 2018: 63.6%FY 2019: -65.4%FY 2020: 76.7%FY 2021: -57.9%FY 2022: 50.6%FY 2023: 17.8%FY 2024: -85.6%FY 2025: 108.9%
FY 2016 FY 2025
Free Cash Flow 167.4%
FY 2016: -27.6%FY 2017: 26.5%FY 2018: -17.5%FY 2019: -48.8%FY 2020: -45.0%FY 2021: -10.2%FY 2022: 25.2%FY 2023: -19.9%FY 2024: -177.9%FY 2025: 167.4%
FY 2016 FY 2025

Financial Health

Current Ratio 5.8×
FY 2016: 2.2×FY 2017: 10.4×FY 2018: 13.1×FY 2019: 4.3×FY 2020: 5.8×FY 2021: 2.8×FY 2022: 2.1×FY 2023: 14.9×FY 2024: 15.7×FY 2025: 5.8×
FY 2016 5y median 5.8× FY 2025
Quick Ratio 5.6×
FY 2016: 1.8×FY 2017: 10.4×FY 2018: 13.1×FY 2019: 4.3×FY 2020: 5.8×FY 2021: 2.8×FY 2022: 2.1×FY 2023: 14.9×FY 2024: 15.7×FY 2025: 5.6×
FY 2016 5y median 5.6× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.2×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -2.4×
FY 2016: 0.4×FY 2017: 1.4×FY 2018: 2.0×FY 2019: 0.7×FY 2020: 2.2×FY 2021: 0.7×FY 2022: 0.7×FY 2023: 4.6×FY 2024: 0.2×FY 2025: -2.4×
FY 2016 5y median 0.7× FY 2025
Interest Coverage 2.7×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: -231×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -812×FY 2025: 2.7×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31